Last week's XA Network's panel on healthcare innovation and investment surfaced some sharp takes on where the industry is heading. A few really stuck out: - Annabel Lin laid out the staggering imbalances in healthcare infrastructure — entire countries like Vietnam relying on a single radiologist, while developed markets stare down a $47 trillion chronic disease burden. - Rio Hoe (Ease Healthcare) made the case for vertical focus in digital health. Their move from women's health to obesity management wasn't just strategy — it was about building deep patient trust in one lane. - Natasha Hui Jin Ng of BetaLife shared a refreshingly practical biotech playbook: build commercial revenue streams alongside your therapeutic pipeline. It de-risks the long R&D runway that sinks so many startups. - Michael Blakey of Cocoon Capital flagged what might be Singapore's biggest missed opportunity — world-class research that hasn't yet been matched by commercial muscle. A lot to chew on, especially around how Southeast Asia's health tech scene is positioning itself for the next decade. Thanks to everyone who participated in the thoughtful discussion. #HealthcareInnovation #DigitalHealth #Biotech #Investment
-
-
-
-
-
+1